Eulry F, Orgiazzi J, Mornex R
Nouv Presse Med. 1977 Oct 8;6(33):2955-8.
In a patient with hyperthyroidism resulting in cachexia, severe cardiac complications and functional renal failure, and a second case of hyperthyroidism refractory to carbimazole as a result of iodine overload, the administration of 1 to 3 g of lithium gluconate every 1 to 3 days, in association with carbimazole, led to persistent clinical and biological improvement in 8 to 16 days. In the first case, the course was complicated by neurological intolerance (blood lithium 0.98 mEq/l) which responded to the temporary interruption of treatment and by a transient escape of thyroid function from the effects of lithium which disappeared after a slight adjustment in the dose. In the second case, the course under treatment was favourable from the outset. Thus in forms of hyperthyroidism in which usual forms of treatment are inadequate and where there is a risk of "acute crises", lithium may be valuable as adjuvant therapy. If the dose is regularly modified in order to obtain a daily blood lithium level of less than 0.60 mEq/l, and on condition of close clinical, electrocardiographic and ionic surveillance, cardiac and renal failure and neuropsychiatric disturbances do not prevent the use of lithium, which the authors feel to be of irreplaceable value.
在一名因甲状腺功能亢进导致恶病质、严重心脏并发症和功能性肾衰竭的患者以及另一名因碘过载而对卡比马唑难治的甲状腺功能亢进患者中,每1至3天给予1至3克葡萄糖酸锂,并联合卡比马唑治疗,在8至16天内使临床和生物学指标持续改善。在第一例患者中,治疗过程因神经耐受性问题(血锂浓度0.98 mEq/l)而复杂化,该问题通过暂时中断治疗得到缓解,还因甲状腺功能对锂的作用出现短暂逃逸,在轻微调整剂量后消失。在第二例患者中,治疗过程从一开始就很顺利。因此,在常规治疗方法不足且存在“急性危机”风险的甲状腺功能亢进形式中,锂作为辅助治疗可能具有重要价值。如果为了使每日血锂水平低于0.60 mEq/l而定期调整剂量,并在密切的临床、心电图和离子监测的条件下,心力衰竭、肾衰竭和神经精神障碍并不妨碍使用锂,作者认为锂具有不可替代的价值。